News Detail
New Delhi, 13 July 2024: The Union health ministry has come up with a draft notification to prohibit advertisements of drugs specified in Schedule G - including anti-diabetes formulations having metformin, all types of insulin and various oncology drugs - without the prior approv......
View Details
Source : Pharmabiz
Union health ministry
advertisements
Schedule G
anti-diabetes
oncology drugs DTAB
Goa
Gazette of India
Schedule Gm Drugs Rules
glibenclamidem aminopterin
L-asparaginase
busulfan
chlorambucil
daunorubicin
hydroxyurea
Related News
- Centre frames draft rules for compounding of offences under Drugs & Cosmetics Act (15-07-2024)
- TGA warning for popular cold and flu medicine after shock death (15-07-2024)
- AiMeD seeks customs duty increase on 95 items in HS Codes of Medical Devices (15-07-2024)
- 7th India-Japan medical product regulatory symposium held at New Delhi (15-07-2024)
- 5 ayurvedic products ruled as drugs by HC (14-07-2024)
- 10 Lakh Yaba Tabs valued ₹32.53 cr seized in Mizoram, two held (14-07-2024)
- Action against drug manufacturer for false labelling of Ketamine Inj (14-07-2024)
- EMA Warns of Anaphylactic Reactions to MS Drug (13-07-2024)
- Drug price regulation leads to decline in availability of essential medicines, study finds (13-07-2024)
- Drug firms’ CEOs to file legal undertaking for exports NOC (13-07-2024)